Hematogenous Dissemination of Breast Cancer Cells From Lymph Nodes Is Mediated by Tumor MicroEnvironment of Metastasis Doorways
Open Access
- 26 October 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 571100
Abstract
In primary breast tumors, cancer cells hematogenously disseminate through doorways in the vasculature composed of three-cell complexes (known as Tumor MicroEnvironment of Metastasis) comprising a perivascular macrophage, a tumor cell overexpressing the actin-regulatory protein Mammalian Enabled (Mena), and an endothelial cell, all in direct physical contact. It has been previously shown that once tumor cells establish lymph node metastases in patients, TMEM doorways form in the metastatic tumor cell nests. However, it has not been established if such lymph node-TMEM doorways actively transit tumor cells into the peripheral circulation and on to tertiary sites. To address this question in this short report, we used a mouse model of lymph node metastasis to demonstrate that TMEM doorways: (1) exist in tumor-positive lymph nodes of mice, (2) are restricted to the blood vascular endothelium, (3) serve as a mechanism for further dissemination to peripheral sites such as to the lungs, and (4) their activity can be abrogated by a pharmaceutical intervention. Our data suggest that cancer cell dissemination via TMEM doorways is a common mechanism of breast cancer cell dissemination to distant sites and thus the pharmacological targeting of TMEM may be necessary, even after resection of the primary tumor, to suppress cancer cell dissemination.Keywords
Funding Information
- National Cancer Institute
This publication has 42 references indexed in Scilit:
- The emerging roles of macrophages in cancer metastasis and response to chemotherapyJournal of Leukocyte Biology, 2019
- A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancernpj Breast Cancer, 2017
- The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine TumorsMolecular Cancer Therapeutics, 2017
- Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanismScience Translational Medicine, 2017
- Extended Time-lapse Intravital Imaging of Real-time Multicellular Dynamics in the Tumor MicroenvironmentJournal of Visualized Experiments, 2016
- Signatures of breast cancer metastasis at a glanceJournal of Cell Science, 2016
- Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage–Derived VEGFACancer Discovery, 2015
- TMEM: a novel breast cancer dissemination marker for the assessment of metastatic riskBiomarkers in Medicine, 2015
- Tumor Microenvironment of Metastasis and Risk of Distant Metastasis of Breast CancerJNCI: Journal of the National Cancer Institute, 2014
- Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous DisseminationClinical Cancer Research, 2009